N-Methyl-1,2,3,4-tetrahydroisoquinoline-7-carboxamide hydrochloride

Catalog No. :
ACRRAT559
CAS No. :
2703779-09-1
Molecular Formula :
C11H15ClN2O
Molecular Weight :
226.71

IUPAC Name:N-methyl-1,2,3,4-tetrahydroisoquinoline-7-carboxamide hydrochloride

N-Methyl-1,2,3,4-tetrahydroisoquinoline-7-carboxamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$1058.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Methyl-1,2,3,4-tetrahydroisoquinoline-7-carboxamide hydrochloride
IUPAC NameN-methyl-1,2,3,4-tetrahydroisoquinoline-7-carboxamide hydrochloride
Molecular FormulaC11H15ClN2O
Molecular Weight226.71
SMILESO=C(C1=CC2=C(C=C1)CCNC2)NC.[H]Cl
InChI KeySQESBGGIBAAXPL-UHFFFAOYSA-N
Synonym7-Isoquinolinecarboxamide, 1,2,3,4-tetrahydro-N-methyl-, hydrochloride (1:1)
CAS No.2703779-09-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRRAT559 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEWLT384 route compound structure diagram
    ACEWLT384220247-69-8 In Stock
  4. Then
  5. ACRRAT559 route product structure diagram
    ACRRAT5592703779-09-1
Inquiry

2. ACRRAT559 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEWLT384 route compound structure diagram
    ACEWLT384220247-69-8 In Stock
  4. Plus
  5. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  6. Then
  7. ACRRAT559 route product structure diagram
    ACRRAT5592703779-09-1
Inquiry

Comments (0)